4.6 Article

Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress

期刊

PSYCHO-ONCOLOGY
卷 25, 期 6, 页码 719-725

出版社

WILEY-BLACKWELL
DOI: 10.1002/pon.3911

关键词

-

资金

  1. HealthWell Foundation
  2. VA Health Services Research and Development (HSR&D) Career Development Award [CDA 13-025]
  3. American Cancer Society Mentored Research Scholar Grant
  4. Greenwall Foundation
  5. Novartis
  6. US National Institutes of Health
  7. US Agency for Healthcare Research and Quality
  8. Robert Wood Johnson Foundation
  9. Pfizer
  10. Eli Lilly
  11. Bristol Meyers Squibb
  12. Helsinn Therapeutics
  13. Amgen
  14. Kanglaite
  15. Alexion
  16. Biovex
  17. DARA Therapeutics
  18. Mi-Co

向作者/读者索取更多资源

BackgroundCancer patients may experience financial distress as a side effect of their care. Little is known about which patients are at greatest risk for altering their care or lifestyle due to treatment-related financial distress. MethodsWe conducted a cross-sectional survey study to determine which patients are at greatest risk for altering their care or lifestyle due to treatment-related financial distress. Eligible patients were adults receiving cancer treatment enrolled between June 2010 and May 2011. We grouped coping strategies as lifestyle altering or care altering. We assessed coping strategies and relationships between covariates using descriptive statistics and analysis of variance. ResultsAmong 174 participants, 89% used at least one lifestyle-altering coping strategy, while 39% used a care-altering strategy. Care-altering coping strategies adopted by patients included the following: not filling a prescription (28%) and taking less medication than prescribed (23%). Lifestyle-altering strategies included the following: spending less on leisure activities (77%), spending less on basics like food and clothing (57%), borrowing money (54%), and spending savings (50%). Younger patients were more likely than older patients to use coping strategies (p<0.001). Lower-income patients adopted care-altering strategies more than higher-income patients (p=0.03). Participants with more education and shorter duration of chemotherapy used lifestyle-altering strategies more than their counterparts (both p<0.05). ConclusionsAs a means of coping with treatment-related financial distress, patients were more likely to use lifestyle-altering approaches, but more than one-third adopted potentially harmful care-altering strategies. Younger age, lower income, higher education, and shorter duration of chemotherapy were characteristics associated with greater use of coping strategies. Copyright (c) 2015 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据